Clinical Trial: Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A 5-Day, Double-Blind, Placebo-Controlled Multicenter Study of Oral YM087 (CI-1025) to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
Brief Summary: Study of efficacy & safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia
Detailed Summary:
Sponsor: Cumberland Pharmaceuticals
Current Primary Outcome: Change in serum sodium from Baseline Safety of each dosing regimen [ Time Frame: Beginning through end of treatment ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Cumberland Pharmaceuticals
Dates:
Date Received: June 25, 2007
Date Started: January 2000
Date Completion:
Last Updated: April 30, 2014
Last Verified: April 2014